Incident Response to SolarWinds Orion Software Compromise for SMEs
SCOTTSDALE, Ariz., March 01, 2021 (GLOBE NEWSWIRE) — In early December 2020, it was revealed…
Month: March 2021
Orion Corporation: Managers’ transactions – Olli Huotari
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2021 at 9.00 EET Orion Corporation: Managers’ transactions…
Orion Corporation: Managers’ transactions – Timo Lappalainen
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2021 at 9.00 EET Orion Corporation: Managers’ transactions…
Orion Corporation: Managers’ transactions – Jari Karlson
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2021 at 9.00 EET Orion Corporation: Managers’ transactions…
Lisa Deschamps Joins Verona Pharma as Non-Executive Director
LONDON and RALEIGH, N.C., March 02, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment of Generalized Myasthenia Gravis
Regulated Information/Inside Information argenx Announces FDA Acceptance of BLA Filing for Efgartigimod for the Treatment…
Orion Corporation: Managers’ transactions – Virve Laitinen
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2021 at 9.00 EET Orion Corporation: Managers’ transactions…
Orion Corporation: Managers’ transactions – Satu Ahomäki
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MARCH 2021 at 9.00 EET Orion Corporation: Managers’ transactions…
Orphazyme reports business highlights and financial results in Annual Report 2020
Orphazyme A/SCompany announcementNo. 06/2021Company Registration No. 32266355 -Advanced arimoclomol in 4 rare disease indications; announced…
Nicox Provides Video Update on Latest Developments
FOR INFORMATION Nicox Provides Video Update on Latest Developments March 2, 2021 – release…
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
ILLUMINATE-301 Continues on Track for Data Later this Month EXTON, Pa., March 01, 2021 (GLOBE…
Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
Management to host conference call at 8:00 AM Eastern Time on Tuesday, March 2, 2021…
PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.
TORONTO, March 01, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB)…
LEXEO Therapeutics Announces License Agreement and Consolidation of Comprehensive Pre-clinical Data Package to Support Cardiac Friedreich’s Ataxia Gene Therapy Program (LX2006)
LEXEO completes license of all intellectual property rights and pre-clinical data associated with Adverum Biotechnologies’…
MediPharm Labs Announces $20 million Bought Deal Equity Financing
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 01,…
Nephros Reports 2020 Fourth Quarter and Full Year Financial Results
Fourth Quarter Net Revenue $2.3 Million, Up 10% Sequentially Over Third QuarterFull Year Revenue $8.6…
Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021
TUSTIN, Calif., March 01, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated…
Enzo Biochem to Report Second Quarter 2021 Financial Results on Monday, March 15
Conference Call and Webcast Scheduled for March 15, 2021, 4:30 pm ET NEW YORK, NY,…
Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021
DURHAM, N.C., March 01, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Agile Therapeutics Reports Fourth Quarter & Full Year 2020 Financial Results; Expands Loan Facility With Perceptive Advisors
Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available Achieved Gross…